Giving men with stage IIA and IIB testicular seminoma a single dose of chemotherapy along with radiotherapy may help improve the effectiveness of treatment.
In addition, this new treatment regimen may help reduce the risk of long-term side effects.
John Schieszer has the story in today’s Medical Minute.
Next post in The Medical Minute
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.